Zhang Lianghui, Jambusaria Ankit, Hong Zhigang, Marsboom Glenn, Toth Peter T, Herbert Brittney-Shea, Malik Asrar B, Rehman Jalees
From Department of Pharmacology (L.Z., A.J., Z.H., G.M., P.T.T., A.B.M., J.R.), Department of Medicine, Division of Cardiology (J.R.), The University of Illinois College of Medicine, Chicago; and Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis (B.-S.H.).
Circulation. 2017 Jun 20;135(25):2505-2523. doi: 10.1161/CIRCULATIONAHA.116.025722. Epub 2017 Apr 5.
The mechanisms underlying the dedifferentiation and lineage conversion of adult human fibroblasts into functional endothelial cells have not yet been fully defined. Furthermore, it is not known whether fibroblast dedifferentiation recapitulates the generation of multipotent progenitors during embryonic development, which give rise to endothelial and hematopoietic cell lineages. Here we established the role of the developmental transcription factor SOX17 in regulating the bilineage conversion of fibroblasts by the generation of intermediate progenitors.
CD34 progenitors were generated after the dedifferentiation of human adult dermal fibroblasts by overexpression of pluripotency transcription factors. Sorted CD34 cells were transdifferentiated into induced endothelial cells and induced erythroblasts using lineage-specific growth factors. The therapeutic potential of the generated cells was assessed in an experimental model of myocardial infarction.
Induced endothelial cells expressed specific endothelial cell surface markers and also exhibited the capacity for cell proliferation and neovascularization. Induced erythroblasts expressed erythroid surface markers and formed erythroid colonies. Endothelial lineage conversion was dependent on the upregulation of the developmental transcription factor SOX17, whereas suppression of SOX17 instead directed the cells toward an erythroid fate. Implantation of these human bipotential CD34 progenitors into nonobese diabetic/severe combined immunodeficiency (NOD-SCID) mice resulted in the formation of microvessels derived from human fibroblasts perfused with mouse and human erythrocytes. Endothelial cells generated from human fibroblasts also showed upregulation of telomerase. Cell implantation markedly improved vascularity and cardiac function after myocardial infarction without any evidence of teratoma formation.
Dedifferentiation of fibroblasts to intermediate CD34 progenitors gives rise to endothelial cells and erythroblasts in a SOX17-dependent manner. These findings identify the intermediate CD34 progenitor state as a critical bifurcation point, which can be tuned to generate functional blood vessels or erythrocytes and salvage ischemic tissue.
成人人类成纤维细胞去分化并向功能性内皮细胞进行谱系转换的潜在机制尚未完全明确。此外,尚不清楚成纤维细胞去分化是否重现了胚胎发育过程中多能祖细胞的产生,而这些祖细胞可分化为内皮细胞和造血细胞谱系。在此,我们通过生成中间祖细胞确定了发育转录因子SOX17在调节成纤维细胞双向谱系转换中的作用。
通过多能转录因子的过表达使人成人真皮成纤维细胞去分化后生成CD34祖细胞。使用谱系特异性生长因子将分选的CD34细胞转分化为诱导性内皮细胞和诱导性成红细胞。在心肌梗死实验模型中评估所生成细胞的治疗潜力。
诱导性内皮细胞表达特异性内皮细胞表面标志物,还表现出细胞增殖和新血管形成的能力。诱导性成红细胞表达红系表面标志物并形成红系集落。内皮谱系转换依赖于发育转录因子SOX17的上调,而抑制SOX17则使细胞走向红系命运。将这些人类双潜能CD34祖细胞植入非肥胖糖尿病/严重联合免疫缺陷(NOD-SCID)小鼠体内,导致形成了源自人类成纤维细胞的微血管,这些微血管中有小鼠和人类红细胞灌注。由人类成纤维细胞生成的内皮细胞也显示出端粒酶上调。细胞植入显著改善了心肌梗死后的血管生成和心脏功能,且没有任何畸胎瘤形成的迹象。
成纤维细胞去分化为中间CD34祖细胞以SOX17依赖的方式产生内皮细胞和成红细胞。这些发现确定中间CD34祖细胞状态为一个关键的分支点,可对其进行调控以生成功能性血管或红细胞并挽救缺血组织。